Kempharm Inc (KMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KMPH | ATNM | ZVRA | ||
| Company | Kempharm Inc | Actinium Pharmaceuticals Inc | Zevra Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 5.83 | 6.90 | 4.56 | ||
| High | 5.97 | 7.48 | 4.64 | ||
| Low | 5.78 | 6.88 | 4.52 | ||
| Last | 5.81 | 7.38 | 4.55 | ||
| Change | -0.02 | +0.51 | +0.03 | ||
| % Change | -0.34% | +7.42% | +0.66% | ||
| Volume | 64,100 | 244,800 | 106,900 | ||
| 20-Day Average Volume | 134,975 | 323,075 | 220,360 | ||
| Previous Close | 5.83 | 6.87 | 4.52 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.54 | 8.01 | 4.74 | ||
| 20-Day Raw Stochastic | 68.26% | 28.35% | 16.84% | ||
| 20-Day Relative Strength | 58.63% | 48.38% | 34.85% | ||
| Weighted Alpha | +13.40 | -19.39 | -26.07 | ||
| Today's Opinion | 56% Buy | 56% Buy | 56% Sell | ||
| Previous Opinion | 40% Buy | 56% Buy | 40% Sell | ||
| Last Month's Opinion | 40% Buy | 88% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.21% since 02/21/23 | +2.93% since 04/22/24 | -0.44% since 04/22/24 | ||
| Low | 5.37 on 02/22/23 | 6.47 on 04/25/24 | 4.48 on 04/26/24 | ||
| High | 6.07 on 02/24/23 | 7.48 on 04/29/24 | 4.68 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | +5.44% since 01/27/23 | -5.75% since 03/28/24 | -21.55% since 03/28/24 | ||
| Low | 5.24 on 02/14/23 | 6.47 on 04/25/24 | 4.39 on 04/19/24 | ||
| High | 6.07 on 02/24/23 | 9.68 on 04/08/24 | 5.49 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | +24.41% since 11/28/22 | +24.45% since 01/29/24 | -26.26% since 01/29/24 | ||
| Low | 4.08 on 12/28/22 | 5.08 on 02/05/24 | 4.39 on 04/19/24 | ||
| High | 6.30 on 01/24/23 | 9.86 on 03/22/24 | 7.28 on 02/20/24 | ||
| 6-Month | |||||
| %Chg | -0.34% since 08/26/22 | +36.67% since 10/27/23 | +4.84% since 10/27/23 | ||
| Low | 4.08 on 12/28/22 | 4.00 on 11/28/23 | 3.89 on 11/13/23 | ||
| High | 6.92 on 09/15/22 | 9.86 on 03/22/24 | 7.28 on 02/20/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 200,474 | 201,950 | 196,285 | ||
| Shares Outstanding, K | 34,505 | 29,396 | 43,426 | ||
| Annual Sales | 28,650,000 | 80,000 | 27,460,000 | ||
| Annual Net Income | -8,560,000 | -48,820,000 | -46,050,000 | ||
| Last Quarter Sales | 2,870,000 | 80,000 | 13,220,000 | ||
| Last Quarter Net Income | -6,620,000 | -9,320,000 | -15,150,000 | ||
| 60-Month Beta | 2.16 | 0.01 | 1.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 11/09/22 | -0.33 on 03/29/24 | -0.40 on 03/28/24 | ||
| Latest Earnings Date | 03/07/23 | 05/20/24 | 05/20/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||